Benfluorex (Mediator^®), notre vigilance en question = Benfluorex (Mediator®), our vigilance in questionFRACHON, Irène.La Presse médicale (1983). 2011, Vol 40, Num 5, pp 459-461, issn 0755-4982, 3 p.Article

Correspondance à propos de l'article: « Benfluorex (Mediator®) et atteintes valvulaires » = Letter on the article: Benfluorex and valvular heart diseaseJOBIC, Yannick; ETIENNE, Yves; TRIBOUILLOY, Christophe et al.La Presse médicale (1983). 2012, Vol 41, Num 3, pp 326-327, issn 0755-4982, 2 p.Article

À propos de l'expertise des dossiers benfluorex (Mediator® et génériques) = About the settlement of litigations concerning the harm caused by benfluorex (Mediator^®)NICOT, Philippe; FRACHON, Irène; HILL, Catherine et al.La Presse médicale (1983). 2013, Vol 42, Num 4, pp 411-418, issn 0755-4982, 8 p., CAH1Article

Benfluorex: in utero exposurePrescrire international (Paris). 2013, Vol 22, Num 135, issn 1167-7422, p. 46Article

Benfluorex : données défavorables en France, mais toujours pas de retrait = Benfluorex and adverse effects french datasLa Revue Prescrire. 2008, Vol 28, Num 300, pp 748-748, issn 0247-7750, 1 p.Article

Benfluorex: des expositions en cours de grossesse ! = Benfluorex: exposures during pregnancyLa Revue Prescrire. 2012, Vol 32, Num 349, issn 0247-7750, p. 833Conference Paper

Benfluorex: valvulopathies, encore = Benfluorex and cardiac valvular diseasesLa Revue Prescrire. 2010, Vol 30, Num 316, issn 0247-7750, p. 114Article

Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphsMACCARONI, Elisabetta; MALPEZZI, Luciana; PANZERI, Walter et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 53, Num 1, pp 1-6, issn 0731-7085, 6 p.Article

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients : An 18 to 34-week, open-label, extension periodMOULI, P; ANDRE, M; ALAWI, H et al.Diabetes & metabolism. 2009, Vol 35, Num 1, pp 64-70, issn 1262-3636, 7 p.Article

Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patientsDEL PRATO, S; ERKELENS, D. W; LEUTENEGGER, M et al.Acta diabetologica (Print). 2003, Vol 40, Num 1, pp 20-27, issn 0940-5429, 8 p.Article

Valvular heart disease in a patient taking benfluorexNOIZE, P; SAUER, M; BRUNEVAL, P et al.Fundamental & clinical pharmacology. 2006, Vol 20, Num 6, pp 577-578, issn 0767-3981, 2 p.Article

Mediator^®: analyse du contenu de la base ACT-IP de la Société française de pharmacie clinique = Mediator^®: Analysis of interventions performed by French hospital pharmacistsCHARPIAT, B; CONORT, O; JUSTE, M et al.Le Pharmacien hospitalier et clinicien (Print). 2014, Vol 49, Num 3, pp 192-196, issn 2211-1042, 5 p.Article

LES VALVULOPATHIES MÉDICAMENTEUSES: Une cause d'essoufflement d'origine cardiovasculaire passée inaperçue durant trente-trois ansENNEZAT, Pierre-Vladimir; TRIBOUILLOY, Christophe; JOBIC, Yannick et al.Cardiologie cardinale. 2014, Vol 8, Num 67, pp 219-232, issn 1960-1646, 14 p.Article

Increased Risk of Left Heart Valve Regurgitation Associated With Benfluorex Use in Patients With Diabetes Mellitus: A Multicenter StudyTRIBOUILLOY, Christophe; RUSINARU, Dan; GARBAN, Thierry et al.Circulation (New York, N.Y.). 2012, Vol 126, Num 24, pp 2852-2858, issn 0009-7322, 7 p.Article

APRÈS MEDIATOR°. Politique du médicament en France : de bonnes mesures annoncées, à compléter, et surtout à faire appliquer = After MEDIATOR°. Drug policy in France: good measures announced, to complete, and especially to enforceLa Revue Prescrire. 2011, Vol 31, Num 335, pp 697-700, issn 0247-7750, 4 p.Article

Fenfluramine-like cardiovascular side-effects of benfluorexBOUTET, K; FRACHON, I; JOBIC, Y et al.The European respiratory journal. 2009, Vol 33, Num 3, pp 684-688, issn 0903-1936, 5 p.Article

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients : An 18-week, randomized, double-blind studyMOULIN, Philippe; ANDRE, Marie; ALAWI, Hasan et al.Diabetes care. 2006, Vol 29, Num 3, pp 515-520, issn 0149-5992, 6 p.Article

Urticaire et choc anaphylactique au benfluorex: Deux observations = Urticaria and anaphalactic shock related to benfluorex. Two casesCHAINE, B; MORAND, J. J; FOLCHETTI, G et al.Annales de dermatologie et de vénéréologie. 1998, Vol 125, Num 3, issn 0151-9638, p. 202Article

Benfluorex antidiabétique ? = Benfluorex antidiabetic?La Revue Prescrire. 1997, Vol 17, Num 173, pp 326-328, issn 0247-7750Article

Exposition au benfluorex: valvulopathies gauches très fréquentesLa Revue Prescrire. 2013, Vol 33, Num 352, issn 0247-7750, p. 111Article

Benfluorex et valvulopathies: publication très tardive = Benfluorex and heart valve diseases : late publicationsLa Revue Prescrire. 2012, Vol 32, Num 349, issn 0247-7750, p. 828Article

Benfluorex: valvulopathies gauches très fréquentes (suite)La Revue Prescrire. 2014, Vol 34, Num 364, issn 0247-7750, p. 109Article

Benfluorex: left heart valve disease very common (continued)Prescrire international (Paris). 2014, Vol 23, Num 149, issn 1167-7422, p. 128Article

Benfluorex and cardiac valve disease: long delay in publicationPrescrire international (Paris). 2013, Vol 22, Num 135, issn 1167-7422, p. 47Article

Benfluorex : hypertensions artérielles pulmonaires et valvulopathies, encore = Benfluorex : pulmonary hypertension and valvulopathies, againLa Revue Prescrire. 2009, Vol 29, Num 307, pp 349-349, issn 0247-7750, 1 p.Article